Form D Explorer

Inspect source fieldsReport a record issue

Form D — Angiocrine Bioscience, Inc.

0001569052-25-000002 · filed Sep 5, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$3,000,000
Reported amount sold
$2,100,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Angiocrine Bioscience, Inc.
CIK
1569052
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
11585 SORRENTO VALLEY RD, STE 109
SAN DIEGO, California 92121
Phone
858-436-8047

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗